Literature DB >> 769677

Simple assay for 5-fluorocytosine in the presence of amphotericin B.

C A Kauffman, J A Carleton, P T Frame.   

Abstract

A simple method for the measurement of 5-fluorocytosine in the presence of amphotericin B is described. The antifungal activity of amphotericin B is abolished by heating serum at 100 C for 45 min. 5-Fluorocytosine is unaffected by this treatment, and serum levels can be subsequently assayed by either tube dilution or disk diffusion methods.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 769677      PMCID: PMC429539          DOI: 10.1128/AAC.9.3.381

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Therapy of cryptococcosis with a combination of flucytosine and amphotericin B.

Authors:  J P Utz; I L Garriques; M A Sande; J F Warner; G L Mandell; R F McGehee; R J Duma; S Shadomy
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226

2.  Rapid microbiological assay for 5-fluorocytosine.

Authors:  D J Schiavone; M D Page; J K Dawborn
Journal:  Br Med J       Date:  1973-11-17

3.  The kinetics of 5-fluorocytosine elimination in man.

Authors:  D N Wade; G Sudlow
Journal:  Aust N Z J Med       Date:  1972-05

4.  Torulopsis glabrata renal infection.

Authors:  C A Kauffman; J S Tan
Journal:  Am J Med       Date:  1974-08       Impact factor: 4.965

5.  A pharmacologic guide to the clinical use of amphotericin B.

Authors:  D D Bindschadler; J E Bennett
Journal:  J Infect Dis       Date:  1969-10       Impact factor: 5.226

6.  5-fluorocytosine and urinary candidiasis.

Authors:  R R Davies; D S Reeves
Journal:  Br Med J       Date:  1971-03-13

7.  Candida endocarditis treated with 5-fluorocytosine.

Authors:  C O Record; J M Skinner; P Sleight; D C Speller
Journal:  Br Med J       Date:  1971-01-30

8.  Rapid, simple bioassay for 5-fluorocytosine in the presence of amphotericin B.

Authors:  R L Kaspar; D J Drutz
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

9.  Pharmacological studies with 5-fluorocytosine.

Authors:  E R Block; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1972-06       Impact factor: 5.191

10.  In vitro studies with 5-fluorocytosine.

Authors:  S Shadomy
Journal:  Appl Microbiol       Date:  1969-06
  10 in total
  6 in total

1.  High-pressure liquid chromatographic assay of Bay n 7133 in human serum.

Authors:  C E Fasching; C E Hughes; R F Hector; L R Peterson
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

Review 2.  Clinical pharmacokinetics of systemic antifungal drugs.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

Review 3.  Treatment of systemic fungal infections: recent progress and current problems.

Authors:  T J Walsh; A Pizzo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

4.  Bone marrow toxicity associated with 5-fluorocytosine therapy.

Authors:  C A Kauffman; P T Frame
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

5.  Simplified bioassay method for measurement of flucytosine or ketoconazole.

Authors:  C A Bodet; J H Jorgensen; D J Drutz
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

6.  Amphotericin B and 5-fluorocytosine: effects on cell-mediated immunity.

Authors:  G A Roselle; C A Kauffman
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.